Larson Financial Group’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$57.5K Buy
280
+72
+35% +$14.3K ﹤0.01% 1545
2026
Q2
$39K Buy
208
+104
+100% +$15.2K ﹤0.01% 1638
2026
Q1
$10.1K Buy
104
+4
+4% +$404 ﹤0.01% 2247
2025
Q4
$7.96K Buy
+100
New +$6.56K ﹤0.01% 2244
2025
Q2
– Sell
-51
Closed -$1.8K – 3473
2025
Q1
$1.8K Buy
51
+25
+96% +$1.02K ﹤0.01% 2198
2024
Q4
$1.14K Hold
26
– – ﹤0.01% 2011
2024
Q3
$1.18K Buy
+26
New +$1.13K ﹤0.01% 1955

Other funds holding RVMD

Larson Financial Group's RVMD Position: Q3 2026 in Review

Larson Financial Group increased its Revolution Medicines (RVMD) stake by 35% in Q3 2026, buying an estimated $14.3K and bringing the position to 280 shares worth $57.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1545.

Larson Financial Group first reported a position in RVMD in Q3 2024 and has held it in 7 quarters since. 753 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Larson Financial Group held 280 shares of Revolution Medicines worth $57.5K as of Q3 2026.
  • Larson Financial Group bought 72 Revolution Medicines shares in Q3 2026, an estimated $14.3K.
  • Revolution Medicines made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #1545 holding.
  • Larson Financial Group first reported a position in Revolution Medicines in Q3 2024 and has held it in 7 quarters since.
  • 753 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.